1333379-35-3

Upstream product

• 1333379-21-7 t-butyl [4-(4-(allylthio)phenoxy)phenyl]carbamate 
• 1333379-22-8 tert-butyl (4-(4-((thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)carbamate 
• 869577-67-3 C₁₅H₁₅NOS 
• 1333379-23-9 4-[4-((thiiran-2-yl)methylsulfonyl)phenoxy]benzamine hydrochloride salt 
• 1333481-74-5 tert-butyl (4-(4-((oxiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)carbamate 
• 5656-44-0 4-(allylthio)phenol 
• 36089-71-1 1-allylthio-4-(4-nitrophenyl)benzene 
• 350-46-9 4-Fluoronitrobenzene 

Downstream Products

• 1333481-65-4 C₂₁H₂₇N₃O₄S₂*ClH 
• 1333379-47-7 C₂₁H₂₇N₃O₄S₂ 

Relevant academic research and scientific papers

GELATINASE INHIBITORS AND PRODRUGS

The invention provides compounds, compositions, and methods for the treatment of diseases, disorders, or conditions that are modulated by matrix metalloproteinases (MMPs). The disease, disorder, or condition can include, for example, stroke, neurological

Selective water-soluble gelatinase inhibitor prodrugs

SB-3CT (1), a selective and potent thiirane-based gelatinase inhibitor, is effective in animal models of cancer metastasis and stroke; however, it is limited by poor aqueous solubility and extensive metabolism. We addressed these issues by blocking the pr